Articles On Alcidion Group (ASX:ALC)

Digital healthcare company Alcidion Group (ALC) says the March quarter was a “very strong” period for the company Alcidion earned $12.5 million in new sales which contributed to nearly $43 million in year-to-date sales At the end of the th...

Alcidion (ASX:ALC) signs an agreement with Northern Territory Health (NT Health) that will see NT Health upgrade from an earlier version of Miya to Alcidion’s current Miya Precision platform NT Health will deploy the latest Miya Precision...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Cann will market its CBD capsules in Australia 4DMedical’s XV LVAS software is being trialed in a hospital in California Polynovo’s record March quarter Cann to market CBD capsules in Australia Cannabis company Cann Group (ASX:CAN) has en...

Digital medical information specialist Alcidion (ALC) signs a five-year agreement with East Lancashire Hospitals NHS Trust in the UK to implement the company’s Miya Precision, an upgrade to the existing ExtraMed patient flow solution The c...

Wall Streeet tumbled overnight on US Fed comments  Fed Governor Lael Brainard said the Fed will start reducing the Fed’s balance sheet in May Bond market also sold off ASX to slide as Wall Street tumbles Local shares are poised to fall to...

Alcidion Group (ALC) signs contract renewal agreements with existing customers Moorfields Eye Hospital and Liverpool Heart and Chest Hospital for the use of its Silverlink Patient Care System (PCS) solution Both hospitals are committing to...

Alcidion (ALC) signs a five-year agreement with Dartford and Gravesham NHS Trust to implement the company’s new Miya Emergency module The two software products are expected to alleviate pressure while focusing priorities for emergency dep...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

ASX Emerging Companies (XEC) index has closed 1.5% on Tuesday Index now over 10% the better since February 22 Tuesday winners: ResApp (ASX:RAP), RiversGold (ASX:RGL)    The ASX Emerging Companies (XEC) index is 1.5% higher in late trade....

Alcidion (ALC) strikes a $1.35 million deal to supply its Miya Flow technology to Herefordshire and Worcestershire Health and Care NHS Trust for five years The NHS trust will deploy the tech across six community hospitals to streamline pat...

MoneyTalks is Stockhead’s regular drill down into what stocks investors are looking at right now. We’ll tap our extensive list of experts to hear what’s hot, their top picks, and what they’re looking out for. Today we hear from Cyan Investm...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Alcidion Group (ALC) signs a five-year agreement with the NHS Tayside with the NHS Tayside health board in Scotland to deploy its Miya Observations and Assessments solution The company says NHS Tayside is the third health board in Scotland...

With all the crazy events going on around the world, many ASX shares have been hammered this year regardless of how the underlying business is going. And that’s exactly the disappointment Cyan portfolio manager Dean fergie relayed to his...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Investing in the small side of the share market carries more risk than other areas. However, if your risk tolerance allows for it, having a bit of exposure to this side of the market could be a good thing for a balanced portfolio given the...

Healthcare technology company Alcidion (ALC) says the first half of FY22 was a “transformational” period for its business The company expanded its market share within the British NHS to 26 per cent with acquisition of Silverlink which was...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

Ask A Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In this edition, SG Hiscock portfolio manager Rory Hunter reveals the 2 medical tech ASX shares that will reward t...

The small end of the Australian share market is home to a number of companies with the potential to grow materially in the future. Four that investors might want to get better acquainted with are listed below. Here’s why they should be on...

Are you looking to add a small cap share or two to your portfolio in the near future? If you are, then you might want to consider one of the ASX shares listed below. Here’s what you need to know about these exciting small cap shares: Alcid...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been given buy ratings and tipped for big things in the future. Here’s what y...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

2021 has been nothing if not eventful. And now, some may say gleefully, it is finally drawing to a close. To celebrate the approaching new year, we asked our Foolish contributors to compile a list of some of the ASX shares experts are sayi...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The past fortnight saw ~$62.79m in big director sales and a more modest ~$20.5m in buys but the biggest buy of the week came from a relatively new gold producer. Emerald Resources (ASX:EMR) director Ross Stanley bought just over $1 million...

You can’t win them all, especially in the stock market investing game. Each month you’ll see some of your ASX shares plunge in value. During market downturns you might even see your entire portfolio in the red. But short term movements, ex...

Welcome to the Market Herald Deal Room for this Friday, where we review the week in capital raising. Cobram Estate Olives (ASX:CBO), which only joined the ASX in August and now has a $1 million SPP opening on Monday after raising $50 mil...

Live on The Australian Investors Podcast this week, your weekly hosts Owen Rask & 7Investing’s Dr Anirban Mahanti talk Magellan Financial Group Ltd (ASX: MFG), US cybersecurity stocks, ASX small-cap Alcidion Group Ltd (ASX: ALC) and mor...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 25 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It’s been a...

There were few major catalysts on Thursday, as the ASX traded flat in a relatively cruisy session following some solid gains this week. Broadly speaking, the ASX has tracked global stock markets higher after a rocky selloff last week that f...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is fighting hard to continue its winning streak but is falling just a touch short. At the time of writing, the benchmark index is down slightly to 7,401.7 points. Four ASX shares tha...

The Alcidion Group Ltd (ASX: ALC) share price is deep in the red today after exiting its trading halt this morning. Shares in the company opened around 14% lower and have remained at that level, trading at 27.5 cents apiece at the time of...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

Alcidion (ALC) successfully completes its placement and institutional entitlement offer and raises $43.4 million Yesterday, the company announced it was looking to raise $55 million to buy patient software specialists, Silverlink PCS Softw...

The ASX had another day of solid gains, hitting a three week high with tech and resources leading the charge. The ASX 200 rose 1.25%, closing at 7,405 and while all sectors were in the green, resources and tech both were the best – gaining...

The ASX finished 0.67% higher, marking the best performance by the Australian bourse since early October. Almost all sectors finished higher with energy and tech – two sectors under siege in recent weeks – recording gains of 2.07% and 1.9%...

The Alcidion Group Ltd (ASX: ALC) share price is frozen today with the company announcing it will acquire Silverlink PCS Software Limited. The healthcare technology company’s shares were at 32 cents before the trading halt was announced j...

Alcidion (ALC) has announced plans to raise $55 million and buy patient software specialists, Silverlink PCS Software The ASX-lister will pay £30 million (A$55.5 million) for the Patient Administration System (PAS) providers, which service...

03 Dec 2021 - Alcidion Group Limited (ASX:ALC), as part of a consortium of digital health partners led by Leidos, has been awarded a contract for an estimated $23.5 million over si…

The ASX 200 Health Index (XHJ) is down by 0.67% at the time of writing, compared to the broader index which is up by 0.47%. Alcidion Group (ASX:ALC) rose nearly 8% this morning, after revealing that it was a member of a consortium awarded a...

The Alcidion Group Ltd (ASX: ALC) share price is on course to end the week on a very positive note. In morning trade, the healthcare technology company’s shares are up 11% to 35 cents. Why is the Alcidion share price rocketing higher? Inve...

Alcidion (ALC) has signed a contract with Leidos Australia to provide its platform to a healthcare IT project for the Commonwealth of Australia Alcidion was selected as part of a consortium for the six-year contract which will see it provi...

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

At the small end of the Australian share market, there are a number of companies with the potential to grow materially in the future. Two that investors may want to get better acquainted with are listed below. Here’s what you need to know...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

If you’re wanting to invest in the small side of the Australian share market, then the three small caps listed below could be worth a closer look. All three have been tipped for big things in the future. Here’s why these small cap ASX shar...

Highlights The Australian government announced a budget for FY2021-2022 to support AI technology in Australia. AI has the potential to overcome the challenges businesses and governments face in their operations. ASX-listed players ALC...